Proteos Inc.

Kalamazoo, MI Part of Nanoimaging Services, Inc.

UEI
GF8FHAQFSEJ6
CAGE
4ANV9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
4717 Campus Dr #900, Kalamazoo, MI 49008, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Proteos Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Pilot scale preparation of HIV-1 P24-GP41 and HIV-2 P24_ENV GP41 proteins Contract · 75D30124P18936 CDC Pittsburgh $67,380
Laboratoy supplies Contract · 75D30123P17815 CDC Pittsburgh $38,213
Laboratory supplies - protein purified ridr-m preparation at 30L culture scale Contract · 75D30121P12424 CDC Pittsburgh $16,286
Lab supplies - protein purified from cell cultures Contract · 75D30120P09924 CDC Pittsburgh $15,338
HIV expression and purification Contract · 75D30118P03114 CDC Pittsburgh $22,740

About Proteos Inc.

Proteos Inc. is a for-profit organization that has been registered to receive federal government awards since June 6, 2005. The company specializes in providing high-quality laboratory supplies and services, particularly in the production of recombinant proteins, to federal agencies. Proteos Inc. has demonstrated expertise in preparing HIV-related proteins, which are crucial for research and public health initiatives. The company's ability to produce specialized proteins in large quantities while maintaining high quality has made it a valuable partner for federal agencies, particularly the Centers for Disease Control and Prevention (CDC).

The federal contract awards to Proteos Inc. primarily involve the production and supply of laboratory materials, with a focus on HIV-related proteins. The company has received multiple purchase orders from the CDC Pittsburgh office for various laboratory supplies, including the preparation of HIV-1 p24-gp41 and HIV-2 p24_env gp41 proteins. These contracts range in value from approximately $15,000 to $67,000, with performance periods typically lasting several months to a year. Notably, Proteos Inc. has been awarded sole-source contracts due to its unique capabilities in producing high-quality recombinant proteins in specific quantities and batches, which is essential for quality assurance and reproducibility in research. The contracts awarded to Proteos Inc. do not have set-aside designations, indicating that the company competes successfully in the open market for these specialized services. The primary funding agency for these contracts has been the CDC, highlighting the company's important role in supporting public health research and initiatives.

SBA capabilities narrative

Proteos is a Contract Research Organization providing custom recombinant proteins for clients. We work with our clients to compliment their internal research and maintain the highest quality of expression and purification services.

Quick answers

What is Proteos Inc.'s UEI?

Proteos Inc.'s Unique Entity ID (UEI) in SAM.gov is GF8FHAQFSEJ6.

What is Proteos Inc.'s CAGE code?

Proteos Inc.'s CAGE code is 4ANV9.

What is Proteos Inc.'s primary NAICS code?

Proteos Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Proteos Inc. located?

Proteos Inc.'s physical address in SAM.gov is 4717 Campus Dr #900, Kalamazoo, MI 49008, USA.

Is Proteos Inc. registered in SAM.gov?

Yes. Proteos Inc.'s SAM.gov registration is active through February 20, 2027.

Who is Proteos Inc.'s parent company?

Proteos Inc. is part of Nanoimaging Services, Inc.

What is Proteos Inc.'s most recent federal award?

Proteos Inc.'s most recent federal contract award is Pilot scale preparation of HIV-1 P24-GP41 and HIV-2 P24_ENV GP41 proteins (75D30124P18936), from CDC Pittsburgh, on June 15, 2024.

On GovTribe

See Proteos Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors